Can We Avoid Axillary Lymph Node Dissection (ALND) in Patients with 1–2 Positive Sentinel/Low Axillary Lymph Nodes (SLN/LAS+) in the Indian Setting?

The ACOSOG Z0011 study, heralded as a “practice changing” trial, suggested that women with T1–2 breast cancer with 1–2 SLN+, undergoing breast conservation therapy, need not be offered further ALND. However, whether these results are applicable to all women in the Indian setting, it remains debatabl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Indian J Surg Oncol
Autors principals: Reddy, A., Nair, Nita S., Mokal, Smruti, Parmar, V., Shet, T., Pathak, R., Chitkara, G., Thakkar, P., Joshi, S., Badwe, R. A.
Format: Artigo
Idioma:Inglês
Publicat: Springer India 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8272788/
https://ncbi.nlm.nih.gov/pubmed/34295070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13193-021-01297-6
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars